Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis-Reference-Cited by-同舟云学术

Cisplatin Monotherapy as a Treatment Option for Patients with HER-2 Negative Breast Cancer Experiencing Hepatic Visceral Crisis or Impending Visceral Crisis

Published:2024-06-04 Issue:3 Volume:12 Page:419-435
ISSN:2366-1070
Container-title:Oncology and Therapy
language:en
Short-container-title:Oncol Ther

Author:

Püsküllüoğlu Mirosława^ORCID,Pieniążek Małgorzata,Rudzińska Agnieszka,Pietruszka Agnieszka,Pacholczak-Madej Renata,Grela-Wojewoda Aleksandra,Ziobro Marek

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40487-024-00280-9.pdf

Reference37 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin [Internet]. 2021 [cited 2022 Feb 10];71:209–49. http://www.ncbi.nlm.nih.gov/pubmed/33538338.

2. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin [Internet]. 2022 [cited 2024 Jan 1];72:524–41. https://pubmed.ncbi.nlm.nih.gov/36190501/.

3. Cardoso F, Paluch-Shimon S, Senkus E, Curigliano G, Aapro MS, André F, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol [Internet]. 2020 [cited 2023 Feb 17];31:1623–49. https://pubmed.ncbi.nlm.nih.gov/32979513/.

4. Yang R, Lu G, Lv Z, Jia L, Cui J. Different treatment regimens in breast cancer visceral crisis: a retrospective cohort study. Front Oncol. 2022;12:1048781.

5. Franzoi MA, Saúde-Conde R, Ferreira SC, Eiger D, Awada A, de Azambuja E. Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience. The Breast. 2021 [cited 2024 Jan 1];57:86. Available from: /pmc/articles/PMC8044724/.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale for the Initiation, Outcomes, and Characteristics of Chemotherapy Following CDK4/6 Inhibitors in Breast Cancer: A Real-World Cohort Study;Cancers;2024-08-20